A new gene-editing technique called CRISPR/Cas9 improved muscle function in live mice with Duchenne muscular dystrophy, establishing its potential as a therapy for humans.
Source: Gene editing improves muscle function in mice with Duchenne muscular dystrophy – Medical News Today
